Filtering

Colonic versus small bowel CD: Same mechanism - same treatment?ECCO'20 Vienna
Year: 2020
Authors: Britta Siegmund
Common and distinct pathways in intestinal and non-intestinal immune mediated inflammatory disorders8th SciCom Workshop
Year: 2020
Authors: Andre Franke
Coronavirus: what should we tell our patientsECCO'20 Vienna
Year: 2020
Authors: Jean-Frédéric Colombel
Decoding the functional impact of a non-coding SNP in the JAK2 locus associated with IBD riskJCC Podcast
Year: 2020
Authors: Christopher Cardinale

Dr Christopher Cardinale describes his work to uncover the effects of a non-coding SNP on signalling through the JAK2 pathway.

Diagnosis, anatomy and physiology in IBD11th N-ECCO School
Year: 2020
Authors: Marc Ferrante
Disease interception – learning from other immune-mediated diseases8th SciCom Workshop
Year: 2020
Authors: Jean-Frédéric Colombel
Do i really need a histopathologist?5th H-ECCO IBD Masterclass
Year: 2020
Authors: James Lindsay
DOP01: Exclusive enteral nutrition for treatment of Adult Crohn's DiseaseECCO'20 Vienna
Year: 2020
Authors: Liz Purcell
DOP02: The dose-dependent effect of enteral nutrition on faecal microbial metabolites of healthy volunteersECCO'20 Vienna
Year: 2020
Authors: Vaios Svolos
DOP03: The impact of elemental diet on the human gut microbial structure and intestinal metabolitesECCO'20 Vienna
Year: 2020
Authors: Jun Miyoshi
DOP04: Matching between donors and patients in fecal microbiota transplantation is important for long-term maintenance on Ulcerative ColitisECCO'20 Vienna
Year: 2020
Authors: Dai Ishikawa
DOP05: Perioperative Dietary Therapy in Inflammatory Bowel DiseaseECCO'20 Vienna
Year: 2020
Authors: Michel Adamina
DOP06: Non-invasive identification of adherent-invasive E. coli in patients with Crohn's DiseaseECCO'20 Vienna
Year: 2020
Authors: Anthony Buisson
DOP07: Long-term results of 4.5 Years of fecal microbiota transplantation for treatment of Refractory Ulcerative ColitisECCO'20 Vienna
Year: 2020
Authors: Ahmet Uygun
DOP08: Deep remission in paediatric Crohn’s Disease is associated with increased abundance of Dialister species and increased valerateECCO'20 Vienna
Year: 2020
Authors: Henry Taylor
DOP10: Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s Disease: Week 16 interim analysis of the STARDUST trial substudyECCO'20 Vienna
Year: 2020
Authors: Torsten Kucharzik
DOP11: Normalisation of faecal calprotectin within 12 months of diagnosis is associated with a reduced risk of disease progression in Crohn's DiseaseECCO'20 Vienna
Year: 2020
Authors: Nikolas Plevris
DOP13: Clinical and endoscopic response to ustekinumab in Crohn’s Disease: Week 16 interim analysis of the STARDUST trialECCO'20 Vienna
Year: 2020
Authors: Silvio Danese
DOP15: An evaluation of the exposure-efficacy relationship for subcutaneous vedolizumab maintenance treatment of Crohn’s Disease: Pharmacokinetic findings from VISIBLE 2ECCO'20 Vienna
Year: 2020
Authors: Shashi Adsul
DOP16: Transmural healing with vedolizumab in patients with active Crohn’s DiseaseECCO'20 Vienna
Year: 2020
Authors: Maria Rosario